Erschienen in:
01.10.2007 | Abstracts
Poster Presentations
verfasst von:
A. Konstantinidis, U. Moser, R. Grohmann, A. Horvath, R. Engel, S. Kasper
Erschienen in:
Drug Safety
|
Ausgabe 10/2007
Einloggen, um Zugang zu erhalten
Excerpt
Introduction: Although psychotropic polypharmacy is widely used in common practice there are still substantial deficits in established knowledge about combination and augmentation therapies.[1] Furthermore, psychiatric textbooks advise monotherapy wherever possible reporting a higher risk of adverse drug reactions under polypharmacy.[2] Rittmansberger reported an increase in the use of psychotropic drugs during the last three decades from 47,8% to 19,6%.[2] …